Tuesday, January 30, 2018 10:56:54 AM
Quantum Medical Transport Announces OTC Markets Tier Change
Jan 30, 2018
OTC Disclosure & News Service
Sugar Land, TX -
Sugar land, Texas January 30, 2018-Quantum Medical Transport, Inc. (DRWN: OTCBB)
Quantum Medical Transport, Inc. is pleased to announce approval by OTC Markets to OTC PINK Current Reporting status. We are very excited to be OTC PINK Current now as this furthers our efforts to provide investor transparency and improve shareholder value. We would like to thank our stakeholders for their patience and supporting our vision.
About Quantum Medical Transport/United Ambulance
QUANTUM MEDICAL TRANSPORT, INC. /UNITED AMBULANCE, LLC is an emergency and non-emergency medical services transportation company that operates in the State of Texas. The Company provides basic and advanced life support ground transport in an emergency and non-emergency setting, 24 hours a day, and seven days a week. The Company makes both local and regional out-of-town services available on a daily dispatch basis.
Management remains focused on providing prompt, high-quality patient care at the Advanced and Basic Life Support levels. Employees will work diligently to achieve goals while maintaining the highest standards of care.
CAUTIONARY STATEMENTS REGARDING FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "believes," "expects," "may," "will," "intends, "plans," "should," "seeks," "pro forma," "anticipates," "estimates," "continues," or other variations thereof (including their use in the negative), or by discussions of strategies, plans or intentions. A number of factors could cause results to differ materially from those anticipated by such forward-looking statements, including those discussed under "Risk Factors" and "Our Business." Forward-looking statements are subject to known and unknown risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons.
Investor Relations:
Ricky Bernard
832-436-1831 x100
info@quantummedicaltransport.com
www.quantummedicaltransport.com
Copyright © 2018 OTC Markets. All Rights Reserved
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM